Stay updated on Margetuximab Clinical Trial

Sign up to get notified when there's something new on the Margetuximab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.2%
    Check dated 2025-04-30T13:52:29.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about the Expanded Access program for margetuximab in treating HER2-positive breast cancer, while a new version number has been added.
    Difference
    14%
    Check dated 2025-04-16T01:58:24.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 14, 2025.
    Difference
    1.0%
    Check dated 2025-04-08T21:58:56.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    3%
    Check dated 2025-02-24T18:33:51.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page has transitioned from MacroGenics to TerSera Therapeutics LLC as the entity responsible for considering requests for expanded access to margetuximab, with updated dates reflecting this change.
    Difference
    3%
    Check dated 2025-02-17T12:54:19.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    The webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    3%
    Check dated 2025-02-10T09:21:16.000Z thumbnail image

Stay in the know with updates to Margetuximab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab Clinical Trial page.